Highridge Medical is going against the trend of shedding a spine unit in favor of focusing on stronger parts of the business.
The spin-off spine business of ZimVie has completed the sale of EBI, its Bone Healing division, to Avista Healthcare Partners.
Related: Alcon agrees to acquire Lensar and its robotic cataract laser system
Highridge said the deal aligns with the company’s strategy to exclusively focus on spine and drive long-term growth through dedicated investment in innovation and expansion of commercial capabilities. Highridge will use the proceeds to accelerate investment in portfolio innovation and commercial expansion.
The Bone Healing division, which specialises in non-invasive and implantable, FDA-approved, bone growth stimulation therapies for spine, orthopedics, and podiatric patients, will now operate as an independent company backed by Avista Healthcare Partners.
“Divesting the Bone Healing division allows Highridge to further sharpen our focus on our most promising growth opportunities. We are committed to driving innovation in partnership with our surgeon customers to deliver innovative spinal solutions to enhance patient outcomes,” said Rebecca Whitney, CEO of Highridge Medical. “We would like to thank the dedicated EBI team and are confident that they will thrive as they continue to focus on innovation and advancing patient care.”
